Anne Marie Trip is a Research Consultant in the Rotterdam Office, the Netherlands. Anne Marie works within the Strategic Market Access and Modeling and Meta-analysis Centers of Excellence. Her main expertise is in conducting (systematic) literature reviews to inform network meta-analyses, global value dossiers and reimbursement dossiers.
Anne Marie has experience with literature reviews of clinical studies, epidemiology, disease burden and economic burden, using the results as input for landscape analyses and strategic advice. Her experience also includes adaptation of cost-effectiveness models. Disease areas she has worked in include vaccines, respiratory diseases, oncology, haematology, mental disorders, autoimmune disorders, and orphan diseases. She has presented work at ISPOR and has published on the use of psycho-stimulants in the Netherlands between 1996 and 2006 in children and adolescents, and in relation to age and sex. Anne Marie holds a Master of Science degree in Pharmacy (University of Groningen, Groningen, The Netherlands). She also pursued a second degree in Health Economics, Policy and Law (Erasmus University Rotterdam, The Netherlands), during which she did an internship at the Pricing and Market Access department in a large innovative pharmaceutical company.